Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Analysts think MURA stock price could increase by 358%

Feb 27, 2025, 12:25 PM
-64.91%
What does MURA do
Mural Oncology Plc is a clinical-stage company developing cytokine-based immunotherapies for cancer using its protein engineering platform. Its portfolio includes Nemvaleukin alfa and a tumor-targeted split IL-12 program.
6 analysts think MURA stock price will increase by 357.52%. The current median analyst target is $17.34 compared to a current stock price of $3.79. The lowest analysts target is $13.13 and the highest analyst target is $18.90.
📡️ Health Care
Price Target

More Signals

Feature in Progress
This section is under development. Check back soon for updates!